{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T00:05:42Z","timestamp":1711670742532},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1995,12]]},"DOI":"10.1212\/wnl.45.12.2279","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:13:48Z","timestamp":1336914828000},"page":"2279-2281","update-policy":"http:\/\/dx.doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["S-Methylation in Parkinson's disease"],"prefix":"10.1212","volume":"45","author":[{"given":"Y.","family":"Nakagawa-Hattori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","first-page":"9","volume":"219","year":"1983","unstructured":"Langston JW, Ballard PA, Tetrud JW, Irwin I. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983;219:979-980.","journal-title":"Science"},{"key":"e_1_3_1_3_2","first-page":"1","volume":"2","year":"1985","unstructured":"Barbeau A, Cloutier T, Roy M, Plasse L, Paris S, Poirier J. Ecogenetics of Parkinson's disease: 4-hydroxylation of debrisoquine. Lancet 1985;2:1213-1216.","journal-title":"Lancet"},{"key":"e_1_3_1_4_2","first-page":"8","volume":"39","year":"1989","unstructured":"Steventon GB, Heafield MTE, Waring RH, Williams AC. Xenobiotic metabolism in Parkinson's disease. Neurology 1989;39:883-887.","journal-title":"Neurology"},{"key":"e_1_3_1_5_2","first-page":"3","volume":"2","year":"1989","unstructured":"Waring RH, Steventon GB, Sturman SG, Heafield MTE, Smith MCG, Williams AC. S-methylation in motor neuron disease and Parkinson's disease. Lancet 1989;2:356-357.","journal-title":"Lancet"},{"key":"e_1_3_1_6_2","unstructured":"Mircheva Y Vidailhet M Marconi R Bonnet AM Beaune P Agid Y. Selective decrease in S-methylation in Parkinson's disease [abstract]. Neurology 1993;43(suppl 2):A154."},{"key":"e_1_3_1_7_2","first-page":"5","volume":"97","year":"1979","unstructured":"Weinshilboum RM, Sladek S, Klumpp S. Human erythrocyte thiolmethyltransferase: radiochemical microassay and biochemical properties. Clin Chim Acta 1979;97:59-71.","journal-title":"Clin Chim Acta"},{"key":"e_1_3_1_8_2","first-page":"5","volume":"34","year":"1983","unstructured":"Keith RA, Loon JV, Wussow LF, Weinshilboum RM. Thiolmethylation pharmacogenetics: heritability of human erythrocyte thiolmethyltransferase activity. Clin Pharmacol Ther 1983;34:521-528.","journal-title":"Clin Pharmacol Ther"},{"key":"e_1_3_1_9_2","first-page":"3","volume":"46","year":"1990","unstructured":"Eishelbaum M, Gross AS. The genetic polymorphism of debrisoquine\/sparteine metabolism: clinical aspects. Pharmacol Ther 1990;46:377-394.","journal-title":"Pharmacol Ther"},{"key":"e_1_3_1_10_2","first-page":"3","volume":"86","year":"1993","unstructured":"Chocair PR, Duley JA, Sabbaga E, Arap S, Simmonds HA, Cameron JS. Fast and slow methylators: do racial differences influence risk of allograft rejection? Q J Med 1993;86:359-363.","journal-title":"Fast and slow methylators: do racial differences influence risk of allograft rejection? Q J Med"},{"key":"e_1_3_1_11_2","first-page":"2","volume":"33","year":"1993","unstructured":"Yoshino H, Hattori Y, Imai H, Narabayashi H, Chiba K. Sparteine oxidation by hepatic cytochrome P-450 in patients with Parkinson's disease. Clin Neurol 1993;33:261-265.","journal-title":"Clin Neurol"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.45.12.2279","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T17:00:00Z","timestamp":1711645200000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.45.12.2279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,12]]},"references-count":10,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1995,12]]}},"alternative-id":["10.1212\/WNL.45.12.2279"],"URL":"https:\/\/doi.org\/10.1212\/wnl.45.12.2279","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,12]]}}}